Showing results (1041-1050 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|August 8, 2018
Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: an update on pharmacogenetics studiesMaría Del Carmen Plaza-Serón, Elena García-Martín, Jose Augusto Agúndez, et al.Pharmacogenomics|June 9, 2017
Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patientsPer DamkierPharmacogenomics|June 9, 2017
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patientsValentina Sini, Andrea Botticelli, Gianluigi Lunardi, et al.Pharmacogenomics|June 9, 2017
Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphateIvana Rizzuto, Essam Ghazaly, Godefridus J PetersPharmacogenomics|June 9, 2017
Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trialRebecca C Pierson, Brandon T Gufford, Zeruesenay Desta, et al.Pharmacogenomics|April 28, 2018
Genotype-guided warfarin therapy: current statusLetícia C Tavares, Leiliane R Marcatto, Paulo C J L SantosPharmacogenomics|April 28, 2018
SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patientsFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.Pharmacogenomics|May 26, 2018
Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patientsOlivia M Dong, Amy Li, Oscar Suzuki, et al.Pharmacogenomics|May 24, 2018
A gene variant near ATM affects the response to metformin and metformin plasma levels: a post hoc analysis of an RCTMattijs Out, Matthijs L Becker, Ron H van Schaik, et al.Pharmacogenomics|May 24, 2018
XPO5 genetic polymorphisms in cancer risk and prognosisAna Sofia Patrão, Francisca Dias, Ana Luísa Teixeira, et al.Pageof 276